Using email to promote additional information products

FDAnews has increased revenues 400 percent since 2000 to an estimated $8 million for 2006, and 80 percent of its new business came from online marketing.

Now you can learn the details of this extraordinary achievement.

Dear fellow publisher,

Have you ever wondered why some traditional print publishers are "suddenly" making a fortune selling information online while others are barely breaking even?

So have I.

I've spent the last decade studying, documenting and decoding the online publishing and marketing systems of successful print publishers who have turned their books, magazines and newsletters into multi-million dollar, niche media empires.

Here's the number one big idea that I've discovered: Human beings can acquire knowledge and competence by modeling and imitation.

In other words, successful companies leave clues about what they're doing that we can all learn and replicate.

Study the proven beliefs, methods, practices, strategies and techniques of other successful businesses and you'll usually find a blueprint that you can follow for your own company's success.

One such company is FDAnews, the subject of our latest (January 2007) Mequoda case study.

You can be reading all about the success of FDAnews in just moments from now for only $97.

Defining a niche market

The truth is, we can take no credit for the success of FDAnews. Their success preceded the formal codification of the Mequoda Method. Nevertheless, we hold out FDAnews as a sterling example of Mequoda Method practice and execution.

FDAnews president Cynthia Carter launched FDAnews.com when she recognized, immediately and intuitively, that the FDA information at her new employer's publishing company was a small portion—perhaps 20 percent of the entire content—but accounted for 80 percent of revenues.

That was in 2000. Today, FDAnews is the premier provider of domestic and international regulatory, legislative and business news and information for executives in industries regulated by the U.S. Food and Drug Administration.

Launching a new website and building a list

When Ms. Carter joined what was then known as Washington Business Information, Inc., the company had 10 subscription-based newsletters that produced 95 percent of its revenue.

When she recognized that the FDA product information accounted for about 80 percent of the company's revenue, Ms. Carter quickly decided to focus on that niche of the business.

She soon sold off all the non-FDA information products, then launched FDAnews.com.

Today, monthly page views of FDAnews.com exceed 530,000, with unique visitors topping 68,000.

FDAnews now has in excess of 75,000 unique names in its marketing file. Each of these is a subscriber to at least one of seven free FDAnews email newsletters and is worth an average of $65.

The extraordinary growth of FDAnews

In the new FDAnews Mequoda Case Study, you can read:

How FDAnews has increased revenues 400 percent since 2000.
How 20 percent of new FDAnews business comes from direct mail; 80 percent of new business comes from online.
How FDAnews newsletter subscription income has remained flat while the company's growth has come from the development of new information products—audio conferences, books, and management reports—and from advertising.

How you can get the FDAnews Mequoda Case Study right now

Now you can own the FDAnews Mequoda Case Study almost instantly.

That's right. You can get your own copy of the complete FDAnews Mequoda Case Study right now, via Internet download.

The price is only $97, and as with all Mequoda products, it's covered by our 10X guarantee.

That means at any time during the next 12 months, if you're dissatisfied in any way with the FDAnews Mequoda Case Study, you can get your investment cheerfully refunded.

If you're not absolutely convinced you received a minimum of 10 times the value for your investment—write to me, and I'll send you a prompt refund of your entire purchase price.

With my sincere wish for your marketing success,